FI103951B1 - Ehkäisyjärjestelmä - Google Patents

Ehkäisyjärjestelmä

Info

Publication number
FI103951B1
FI103951B1 FI903106A FI903106A FI103951B1 FI 103951 B1 FI103951 B1 FI 103951B1 FI 903106 A FI903106 A FI 903106A FI 903106 A FI903106 A FI 903106A FI 103951 B1 FI103951 B1 FI 103951B1
Authority
FI
Finland
Prior art keywords
day
progestin
stage
composition
follow
Prior art date
Application number
FI903106A
Other languages
English (en)
Swedish (sv)
Other versions
FI903106A0 (fi
FI103951B (fi
Inventor
Samuel A Pasquale
Original Assignee
Samuel A Pasquale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22989203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI103951(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Samuel A Pasquale filed Critical Samuel A Pasquale
Publication of FI903106A0 publication Critical patent/FI903106A0/fi
Application granted granted Critical
Publication of FI103951B1 publication Critical patent/FI103951B1/fi
Publication of FI103951B publication Critical patent/FI103951B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
FI903106A 1988-10-20 1990-06-20 Ehkäisyjärjestelmä FI103951B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/260,447 US4921843A (en) 1988-10-20 1988-10-20 Contraception system and method
US26044788 1988-10-20
PCT/US1989/004697 WO1990004330A1 (en) 1988-10-20 1989-10-19 Contraception system and method
US8904697 1989-10-19

Publications (3)

Publication Number Publication Date
FI903106A0 FI903106A0 (fi) 1990-06-20
FI103951B1 true FI103951B1 (fi) 1999-10-29
FI103951B FI103951B (fi) 1999-10-29

Family

ID=22989203

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903106A FI103951B (fi) 1988-10-20 1990-06-20 Ehkäisyjärjestelmä

Country Status (15)

Country Link
US (1) US4921843A (fi)
EP (1) EP0397823B1 (fi)
JP (1) JP3001216B2 (fi)
KR (1) KR0182283B1 (fi)
AT (1) ATE175353T1 (fi)
AU (1) AU620940B2 (fi)
CA (1) CA2001144C (fi)
DE (1) DE68928897T2 (fi)
FI (1) FI103951B (fi)
HU (2) HUT51899A (fi)
IL (1) IL92069A0 (fi)
NZ (1) NZ231091A (fi)
PT (1) PT92069B (fi)
WO (1) WO1990004330A1 (fi)
ZA (1) ZA897977B (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
DE4104385C1 (fi) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
WO1998004267A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
JP2001513566A (ja) * 1997-08-27 2001-09-04 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物
EP1148884A4 (en) * 1998-11-12 2003-06-11 Warner Chilcott Lab Ireland Lt Contraceptive with graded progestin
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
CN1183904C (zh) * 1999-02-26 2005-01-12 盐野义制药株式会社 改进了服用性的咀嚼型软胶囊剂及其制法
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
TR200400183T4 (tr) * 2001-05-23 2004-02-23 Pantarhei Bioscience B.V. Hormonal kontrasepsiyon için vasıta ve metot
WO2003049744A1 (en) * 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
WO2005049142A2 (en) * 2003-11-14 2005-06-02 Warner Chilcott Company, Inc. Graduated estrogen contraceptive
EP1550447A1 (en) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstrual cycle control and improvement of conception rates in females
ES2397983T3 (es) * 2004-03-19 2013-03-12 Warner Chilcott Company, Llc Procedimiento anticonceptivo oral multifásico de ciclo prolongado
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (fi) * 1966-11-02 1968-05-03
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption

Also Published As

Publication number Publication date
DE68928897D1 (de) 1999-02-18
EP0397823B1 (en) 1999-01-07
JPH03502932A (ja) 1991-07-04
IL92069A0 (en) 1990-07-12
KR900701277A (ko) 1990-12-01
PT92069B (pt) 1995-06-30
AU620940B2 (en) 1992-02-27
FI903106A0 (fi) 1990-06-20
PT92069A (pt) 1990-04-30
EP0397823A4 (en) 1991-04-03
WO1990004330A1 (en) 1990-05-03
KR0182283B1 (ko) 1999-05-01
FI103951B (fi) 1999-10-29
CA2001144C (en) 1999-07-20
CA2001144A1 (en) 1990-04-20
US4921843A (en) 1990-05-01
AU4497089A (en) 1990-05-14
NZ231091A (en) 1995-12-21
ATE175353T1 (de) 1999-01-15
HUT51899A (en) 1990-06-28
DE68928897T2 (de) 1999-07-29
ZA897977B (en) 1990-07-25
EP0397823A1 (en) 1990-11-22
JP3001216B2 (ja) 2000-01-24
HU211931A9 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
FI103951B1 (fi) Ehkäisyjärjestelmä
NL300025I1 (nl) Combinatie doseringsvorm voor vrouwen in de pre-menopauze.
NO976067L (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
CA2188907A1 (en) Combination compound for contraception based on natural estrogen
DE69804918T2 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
DE69710896D1 (en) Progestogen-anti-progestogen therapien
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
NZ504351A (en) Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
TW324663B (en) Interferon-ω(IFN-ω) as anti-HIV (human immune deficiency virus) agent

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SAVIENT PHARMACEUTICALS, INC.